Questions for FITZGERALD CONTRACEPTIVES Flashcards
Which of the following is a contraindication to estrogen/progestin-containing methods (combined oral contraception [COC], patch [Ortho Evra®], or ring [NuvaRing®])?
A. mother with a history of breast cancer
B. personal history of hepatitis A at age 10 years
C. presence of factor V Leiden mutation
D. cigarette smoking one pack per day in a 22-year-old
C
- A 22-year-old woman taking a 35-mcg ethinyl estradiol COC calls after forgetting to take her pills for 2 consecutive days. She is 2 weeks into the pack. You advise her to:
A. take the last pill missed immediately, even if this means taking two pills today.
B. discard two pills and take two pills today.
C. discard the rest of the pack and start a new pack with the first day of her next menses.
D. continue taking one pill daily for the rest of the cycle.
A
- When counseling a woman about COC use, you advise that:
A. long-term use of COC is discouraged because the body needs a “rest” from birth control pills from time to time.
B. fertility is often delayed for many months after discontinuation of COC.
C. there is an increase in the rate of breast cancer after protracted use of COC.
D. premenstrual syndrome symptoms are often improved with use of COC.
D
- Noncontraceptive benefits of COC use include a decrease in all of the following except:
A. iron-deficiency anemia
. B. pelvic inflammatory disease (PID).
C. cervicitis.
D. ovarian cancer.
C
- Which of the following women is the best candidate for progestin-only pill (POP) use?
A. an 18-year-old woman who frequently forgets to take prescribed medications
B. a 28-year-old woman with multiple sexual partners
C. a 32-year-old woman with adequately controlled hypertension
D. a 26-year-old woman who wants to use the pill to help “regulate” her menstrual cycle
D
- The most common reasons for discontinuing combined oral contraception use is breakthrough bleeding and:
A. nausea/vomiting.
B. inconvenience of use.
C. cost
. D. high failure rate.
B
- A 38-year-old nulliparous woman who smokes two and a half packs a day is in an “on-and-off” relationship. The woman presents seeking contraception. Which of the following represents the most appropriate method?
A. contraceptive ring (NuvaRing®)
B. COC
C. contraceptive patch (Ortho Evra®)
D. vaginal diaphragm
D
- Due to an increased risk of blood clots, an alternative to the contraceptive ring (NuvaRing®) or patch (Ortho Evra®) is preferred in all of the following women except:
A. a 42-year-old nulliparous woman with type 2 diabetes mellitus and high LDL.
B. a 31-year-old woman with a history of naturally occurring multiple gestation pregnancy.
C. a 28-year-old who smokes >15 cigarettes per day.
D. a 33-year-old with a family history of venous thrombosis.
B
- Which of the following statements is true concerning vaginal diaphragm use?
A. When the device is in place, the woman is aware that the diaphragm fits snugly against the vaginal walls.
B. This is a suitable form of contraception for women with recurrent urinary tract infection.
C. After the device is inserted, the cervix should be smoothly covered.
D. The device should be removed within 2 hours of coitus to minimize the risk of infection.
C
- According to the United States Medical Eligibility Criteria (US MEC) for Contraception Use, which of the following is a clinical condition in which the use of a copper-containing intrauterine device (Cu-IUD) or levonorgestrel-releasing IUD (LNG-IUD) should be approached with caution?
A. uncomplicated valvular heart disease
B. current pelvic inflammatory disease
C. hypertension
D. dysmenorrhea
B
11.Which of the following is the most appropriate response to a 27-year-old woman who is taking phenytoin (Dilantin®) for the treatment of a seizure disorder and is requesting hormonal contraception?
A. “A barrier method would be the preferable choice.”
B. “COC is the best option.”
C. “Depo-Provera® (medroxyprogesterone acetate in a depot injection [DMPA]) use will likely not interact with your seizure medication.”
D. “Cu-IUD or LNG-IUD use is contraindicated.”
C
- Which of the following is commonly found after 1 year of using DMPA (Depo-Provera®)?
A. weight gain
B. hypermenorrhea
C. acne
D. rapid return of fertility when discontinued
A
13 to 17. According to the United States Medical Eligibility Criteria (US MEC) for Contraception Use, indicate the appropriate US MEC category (1, 2, 3, or 4) for each candidate for combined hormonal contraceptives (i.e., combined oral contraceptive, patch, or vaginal ring). .
- a 37-year-old woman who smokes 10 cigarettes per day
- a 29-year-old woman with PID
- a 45-year-old woman with history of migraine
- a 32-year-old woman breastfeeding a 6-month-old infant
- a 28-year-old woman with type 1 diabetes mellitus without vascular disease
\
13: Category 3
14: Category 1
15: Category: 4
16: category 2
17: category 2
According to the United States Medical Eligibility Criteria for Contraception Use, indicate the appropriate US MEC category (1, 2, 3, or 4) for each candidate for a Cu-IUD or LNG-IUD.
- a 45-year-old woman with fibroids with uterine cavity distortion
- a 33-year-old woman who smokes two packs per day
- a 25-year-old woman with adequately controlled hypertension
- a 33-year-old woman with family history of breast cancer in a second-degree relative
18: Category 4
19. category 1
20, Category 1
- category 1
As you prescribe COC containing the progestin drospirenone (Loryna™, Ocella®, Vestura®, Yasmin®, Yaz®), you offer the following advice: A. “Always take this pill on a full stomach.” B. “You should not take acetaminophen when using this birth control pill.” C. “Avoid using potassium-containing salt substitutes.” D. “You will likely notice that premenstrual syndrome symptoms might become worse.”
C
